Cataract among Patients with Renal Transplantation in a Tertiary Care Centre: A Descriptive Cross-sectional Study

JNMA J Nepal Med Assoc. 2023 Jan 1;61(257):64-67. doi: 10.31729/jnma.7946.

Abstract

Introduction: Intensive immunosuppressant therapy after renal transplantation has found to cause systemic and ocular side effects among them is cataracts. Studies on a similar topic have still remained explored in our setting. The aim of the study was to find out the prevalence of cataract among patients with renal transplantation in a tertiary care centre.

Methods: This descriptive cross-sectional study was conducted among patients of renal transplantation at tertiary care centres from 1 May 2021 to 31 October 2021. The data was collected after the ethical approval from Institutional Review Committee [Reference number: 397(6-11) e2077/078]. Study proforma recorded the number of patients with cataracts, duration of steroid use, mean age and other comorbidities. A convenience sampling method was used. Point estimate and 95% Confidence Interval were calculated.

Results: Out of 31 renal transplant patients, 10 (32.26%) (15.80-48.72, 95% Confidence Interval) had cataract.

Conclusions: The prevalence of cataract among renal transplantation patients was found to be lower than similar studies done in similar settings.

Keywords: cataract; prevalence; renal transplantation; steroid.

MeSH terms

  • Cataract* / epidemiology
  • Cross-Sectional Studies
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Kidney Transplantation*
  • Tertiary Care Centers